Eotaxin Rhesus Macaque, also known as CCL11 (Chemokine (C-C motif) ligand 11), is a CC chemokine critical for eosinophil recruitment in inflammatory and allergic responses. It is a homolog of human eotaxin-1 and shares structural and functional similarities with other eotaxins across species. In rhesus macaques (Macaca mulatta), this chemokine is primarily involved in eosinophil chemotaxis, acting through the CCR3 receptor.
Eotaxin Rhesus Macaque mediates eosinophil recruitment via CCR3, a receptor expressed on eosinophils, basophils, and subset T-cells. Key functional insights include:
Eosinophil Migration: Induces dose-dependent chemotaxis (EC₅₀: ~1–10 ng/mL) .
Cross-Desensitization: Reduces calcium flux responses to RANTES and MCP-3 in eosinophils, indicating shared CCR3 signaling pathways .
Cellular Activation: Upregulates integrins (e.g., CD11b) and enhances eosinophil adhesion to endothelial cells .
Allergic Inflammation: Chronic allergen exposure (e.g., house dust mite) elevates eotaxin-1 in lung epithelium, correlating with eosinophil infiltration .
Aging-Related Inflammation: Elevated plasma eotaxin levels in aged rhesus macaques correlate with systemic pro-inflammatory cytokines (e.g., TNF-α, IL-6) .
Aeroallergen Exposure: Repeated exposure to Dermatophagoides farinae aerosols in infant macaques induces eotaxin-1 expression in airway epithelia, recruiting eosinophils and dendritic cells to nerve fiber bundles .
Tissue-Specific Expression: Eotaxin-1 is more abundant in tracheal epithelium compared to distal airways, aligning with eosinophil distribution .
Pro-Inflammatory Signature: Old rhesus macaques (≥20 years) exhibit 45% higher plasma eotaxin levels than young animals, associated with gut barrier dysfunction and systemic inflammation .
RAB1797 (Sigma-Aldrich):
Novus Biologicals CCL11:
CCR3 Inhibition: Blockade of eotaxin/CCR3 axis reduces eosinophilic inflammation in asthma and parasitic diseases, validated in rhesus models .
Biomarker Potential: Elevated eotaxin levels in aging macaques suggest its utility as a marker for inflammaging-linked diseases .
Eotaxin encompasses a family of CC chemokines (including eotaxin-1, eotaxin-2, and eotaxin-3) that play crucial roles in eosinophil recruitment during inflammatory responses in rhesus macaques. These chemokines function by binding to CCR3 receptors, facilitating eosinophil migration into affected tissues. In rhesus macaques, eotaxins are particularly important in allergic airway inflammation, with distinct expression patterns across different airway compartments. Research indicates that eotaxin-3 shows the most pronounced upregulation in response to allergen exposure compared to other eotaxin family members, suggesting its primary involvement in eosinophilic recruitment in rhesus macaque airway inflammation .
Studies have demonstrated that house dust mite (HDM) aeroallergen exposure in infant rhesus macaques produces differential effects on eotaxin family members. While eotaxin (eotaxin-1) shows modest increases of approximately 2-3 fold over controls in intrapulmonary airways, eotaxin-2 expression is even lower (<2 fold). In contrast, eotaxin-3 exhibits significantly higher expression levels, peaking at approximately 7-fold over controls within midlevel intrapulmonary airways. Statistical analysis confirms that eotaxin-3 mRNA expression levels in HDM-exposed monkey airways are significantly greater than eotaxin-1 (P = 0.0073, by two-way ANOVA) . This expression pattern suggests that eotaxin-3 may play a more dominant role in allergen-induced inflammatory responses in rhesus macaque airways.
Infant rhesus macaques provide a valuable model for studying early-life immune responses and development of allergic diseases. Their respiratory and immune systems more closely resemble human infants than rodent models, making them particularly relevant for investigating developmental immunology. Research protocols typically introduce 1-2 day old macaques to allergen exposure chambers to examine how early exposures influence immune development and allergic sensitization. The controlled timing of exposure allows researchers to precisely track developmental patterns of chemokine expression and inflammatory responses. Additionally, infant macaques exhibit comparable weight gain patterns between control and allergen-exposed groups, providing a stable baseline for interpreting experimental results .
Chronic house dust mite (HDM) aeroallergen exposure during infancy produces a distinct anatomical pattern of eotaxin-3 expression across airway generations in rhesus macaques. Quantitative analysis reveals that expression levels are significantly affected by airway generation (P = 0.0285, by one-way ANOVA), with peak expression occurring in midlevel intrapulmonary airways at approximately 7-fold over controls. The trachea also shows elevated eotaxin-3 mRNA expression compared to controls, though not to the same extent as midlevel airways. This non-uniform distribution of eotaxin-3 expression correlates with the spatial recruitment of eosinophils observed in these airway compartments, suggesting a direct relationship between localized eotaxin-3 expression and targeted eosinophil migration into specific airway microenvironments .
Researchers employ a multi-stage approach to accurately quantify differential eotaxin expression:
Microdissection technique: Conducting airways are precisely microdissected from parenchyma, with samples collected from three distinct regions: proximal intrapulmonary airway, midlevel airway (containing the last generation of cartilaginous subsegmental bronchi), and respiratory bronchiole.
Comparative expression analysis: Each HDM-exposed monkey is compared with a pooled value from 4-5 filtered air age-matched control animals, with 2-3 replicates for each airway generation.
Statistical validation: One-way ANOVA is used to determine significance of airway generation effects, while two-way ANOVA compares relative expression levels between different eotaxin family members.
Protein-level confirmation: In addition to mRNA analysis, immunohistochemical techniques using specific antibodies (such as biotinylated goat anti-human eotaxin-3) followed by fluorescent detection methods (streptavidin ALEXA 488) confirm protein-level expression patterns .
Researchers employ a multi-parameter approach to establish correlations between eotaxin expression and eosinophil recruitment:
Cellular identification: Eosinophils are detected using mouse anti-human major basic protein antibody (clone BMK-13), which has been validated for cross-reactivity with rhesus macaque eosinophils.
Receptor analysis: CCR3 receptor expression (the primary receptor for eotaxins) is detected using mouse anti-rhesus CCR3 (clone 5B9) followed by goat anti-mouse ALEXA 488 for visualization.
Spatial mapping: The distribution of eosinophils is mapped across five different airway generations and compartments, allowing for precise spatial correlation with eotaxin expression patterns.
Quantitative association: Statistical methods are applied to determine the strength of association between local eotaxin levels and eosinophil density in corresponding tissue regions .
When designing aeroallergen exposure protocols for rhesus macaques, researchers must consider several critical parameters:
Age at exposure initiation: Typically beginning at 1-2 days of age for developmental studies.
Exposure chamber specifications: Chambers should be approximately 4.2 m³ capacity with ventilation rates of 30 changes per hour with filtered air.
Group housing considerations: Multiple animals (e.g., three) may be housed in each exposure chamber throughout the study to maintain similar environmental conditions.
Exposure schedule: Standardized protocols such as 2-hour exposures per day, 3 days per week (Monday, Wednesday, Friday), for a total of 8 weeks provide consistent allergen exposure.
Allergen concentration monitoring: Protein concentration of allergen aerosols should be precisely measured (e.g., 506 ± 38 μg/m³/day) to ensure consistent dosing.
Control animal selection: Control animals should be matched for age, weight, and negative intradermal skin test reactivity to the allergen being studied .
Weight monitoring: Regular body weight measurements to ensure comparable weight gain between control and experimental groups, confirming that any observed differences are not due to general health effects .
Selection and preparation of rhesus macaques for eotaxin studies should follow this systematic approach:
Initial screening: Perform physical examinations and intradermal skin testing to select animals with negative reactivity to the allergen being studied.
Age consideration: For developmental studies, select animals within 1-2 days of age; for studies of mature responses, age-matching is critical.
Weight standardization: Ensure comparable body weight between control and experimental groups at study initiation (e.g., control: mean = 0.508 ± 0.027 kg; HDM: mean = 0.510 ± 0.018 kg).
Housing acclimatization: Allow animals to acclimatize to exposure chambers before beginning experimental procedures.
Baseline measurements: Collect baseline samples for relevant parameters before allergen exposure.
Group assignment: Randomly assign animals to experimental and control groups to minimize selection bias .
For optimal eotaxin expression analysis in rhesus macaque tissues:
Precise airway microdissection: Conduct systematic microdissection to separate conducting airways from parenchyma, collecting samples from distinct airway generations (proximal intrapulmonary airway, midlevel airway, and respiratory bronchiole).
Sample preservation: Immediately process or preserve tissues to maintain RNA and protein integrity.
Comparative analysis design: Compare HDM-exposed monkeys with a pool of values from 4-5 filtered air age-matched control animals, with 2-3 replicates for each airway generation.
mRNA expression analysis: Employ sensitive quantitative techniques to assess relative chemokine gene expression levels.
Protein detection: For eotaxin-3 protein detection, use validated antibodies such as biotinylated goat anti-human eotaxin-3 followed by appropriate secondary detection systems (e.g., streptavidin ALEXA 488) .
While the provided search results don't directly compare eotaxin expression across different primate models, the methodology used for rhesus macaques can be contextualized within broader primate research. Rhesus macaques (Macaca mulatta) serve as a valuable model due to their phylogenetic proximity to humans and similar immune system components. When studying chemokine expression patterns, researchers must consider species-specific differences in receptor binding and signaling pathways.
The extensive genetic characterization of rhesus macaques, including their germline mutation rate (0.77 × 10⁻⁸ de novo mutations per site per generation) , provides important context for interpreting gene expression data. This genetic understanding helps researchers distinguish between conserved immune pathways and species-specific adaptations in chemokine responses. When comparing eotaxin studies across primate models, researchers should consider both evolutionary conservation and divergence of these immune mediators.
Advantages:
Anatomical similarity to humans: Rhesus macaque airways share significant structural homology with human airways, including similar bronchial branching patterns and cellular composition.
Immune system correspondence: Their immune system closely resembles human immune responses, particularly in terms of eosinophil biology and chemokine signaling.
Developmental relevance: Infant rhesus macaques provide a developmentally appropriate model for studying early-life immune responses and sensitization, which is difficult to model in many other species.
Experimental control: The ability to precisely control exposure conditions, timing, and dosage in purpose-built exposure chambers allows for highly reproducible experimental conditions .
Limitations:
Resource intensity: Maintaining rhesus macaque colonies requires specialized facilities, expertise, and substantial resources.
Sample size constraints: Studies typically involve relatively small numbers of animals (e.g., n = 6 for exposure groups) , which can limit statistical power.
Genetic variability: While less than humans, natural genetic variation between individual macaques can introduce experimental variability.
Ethical considerations: Working with non-human primates involves important ethical considerations that may limit certain experimental approaches.
Optimal molecular techniques for quantifying eotaxin gene expression in rhesus macaque tissues include:
RT-qPCR: Real-time quantitative PCR with rhesus-specific primers for eotaxin family members provides sensitive quantification of mRNA expression levels.
RNA-seq: For unbiased transcriptomic profiling, RNA sequencing can detect novel transcripts and splice variants of eotaxin genes.
Digital droplet PCR: This technique offers absolute quantification with higher precision for low-abundance transcripts.
In situ hybridization: Enables visualization of spatial distribution of eotaxin mRNA expression within intact tissue sections.
Housekeeping gene selection: Careful selection and validation of appropriate reference genes for normalization is essential, as expression of traditional housekeeping genes may vary across airway generations .
Validation of antibodies for rhesus macaque eotaxins requires a systematic approach:
Cross-reactivity testing: Test antibodies developed against human eotaxins for cross-reactivity with rhesus macaque proteins. For example, biotinylated goat anti-human eotaxin-3 has been successfully used for rhesus macaque studies .
Positive and negative controls: Include appropriate controls, including tissue samples known to express or lack the target protein.
Specificity verification: Confirm specificity through blocking peptides, knockout controls, or competitive binding assays.
Multiple detection methods: Validate findings using complementary techniques such as Western blotting, immunofluorescence, and ELISA.
Correlation with mRNA expression: Compare protein detection patterns with mRNA expression data to confirm biological relevance .
Recommended statistical approaches include:
ANOVA models: One-way ANOVA to determine significance of airway generation effects (as used to demonstrate eotaxin-3 mRNA expression was significantly affected by airway generation, P = 0.0285) .
Multiple comparisons: Two-way ANOVA for comparing expression levels between different eotaxin family members across airway generations (used to show eotaxin-3 levels were significantly greater than eotaxin-1, P = 0.0073) .
Normalization strategies: Careful normalization to control for technical variations, typically using multiple reference genes.
Repeated measures designs: When examining multiple airway generations from the same animal, repeated measures statistical approaches may be appropriate.
Data presentation: Expression should be reported as fold-change relative to controls with appropriate confidence intervals to facilitate interpretation .
Future research could benefit from integrating genomic approaches with traditional eotaxin expression studies. Given the established germline mutation rate in rhesus macaques (0.77 × 10⁻⁸ per site per generation) , researchers could examine genetic variations in eotaxin genes and their regulatory regions across individual macaques. High-coverage genome sequencing (approximately 76× per individual) could identify polymorphisms potentially influencing eotaxin expression levels or receptor binding affinity.
Additionally, epigenetic profiling of airway tissues could reveal how environmental exposures affect chromatin accessibility and transcription factor binding at eotaxin gene loci, providing mechanistic insights into allergic sensitization. These genomic approaches would complement traditional expression studies to create a more comprehensive understanding of eotaxin biology in primate models.
Understanding spatial and temporal patterns of eotaxin expression in rhesus macaques could inform targeted therapeutic approaches for human allergic conditions. The observation that eotaxin-3 shows significantly higher upregulation than other family members, with peak expression in midlevel airways , suggests that therapies specifically targeting this chemokine might be more effective than broad-spectrum approaches.
Similar to the successful targeting approach demonstrated with humanized monoclonal antibodies in rhesus macaque models of other conditions , anti-eotaxin antibodies with specific anatomical distribution profiles could be developed. The identification of airway microenvironments with preferential eotaxin expression and eosinophil recruitment provides valuable insights for developing targeted immunomodulatory therapies that efficiently reach the most affected sites within the lung during allergic responses .
The CCL11 gene is encoded on three exons and is located on chromosome 17 in humans . The recombinant form of CCL11 from Rhesus Macaque is a single non-glycosylated polypeptide chain containing 74 amino acids . This recombinant protein is expressed in E. coli and purified using high-performance liquid chromatography (HPLC) and validated for bioactivity .
CCL11 selectively recruits eosinophils by inducing their chemotaxis, which is the movement of cells in response to chemical stimuli . This chemotactic activity is mediated through its binding to G-protein-linked receptors, specifically chemokine receptors such as CCR2, CCR3, and CCR5 . The biological activity of recombinant CCL11 is determined by a chemotaxis bioassay using human peripheral blood eosinophils, with effective concentrations ranging from 0.1 to 10.0 ng/mL .
Recombinant Rhesus Macaque CCL11 is used in various research applications, including studies on allergic responses and eosinophil-related diseases . The protein is highly pure, with a purity greater than 98% as determined by SDS-PAGE and HPLC . It is typically lyophilized and should be stored at -20 to -70°C for long-term storage .
The role of CCL11 in allergic responses makes it a significant target for research in conditions such as asthma, allergic rhinitis, and other eosinophil-associated diseases . By understanding the mechanisms through which CCL11 operates, researchers can develop better therapeutic strategies to manage and treat these conditions.